Healthcare - Biotechnology - NASDAQ - US
$ 0.71
0 %
$ 4.24 M
Market Cap
-0.67
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
109.84%
EBIT
Estimate
--148.86%
Net Income
Estimate
27.31%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Fresh Tracks Therapeutics, Inc.
FRTX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart FRTX
EBIT FORECAST
EBIT Forecast Chart FRTX
NET INCOME FORECAST
Net Income Chart FRTX